In 2017, the FDA approved semaglutide, an injectable GLP-1 agonist medication sold under the name Ozempic, for the management of type 2 diabetes. Later, the pharmaceutical company that makes Ozempic ...

Meeting patient needs and achieving high quality are common goals for all stakeholders. It is frequently said that there are several sides to every story, especially when the story results in strongly ...

Technical, regulatory, and personnel considerations characterize pharmaceutical compounding. Pharmaceutical compounding comprises activities associated with preparations that are not commercially ...

Pharmacy compounding is one of the topics in the EU Pharma Law Package that has perhaps received less attention compared to topics such as regulatory exclusivity rights, shortages, and sustainability.

In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...

WEST LAFAYETTE, Ind., and INDIANAPOLIS – A Purdue-related startup is developing the first USP 797 certified, virtual pharmacy cleanroom laboratory for students and other industry professionals to gain ...

The CEO of Revelation Pharma discusses how compounding pharmacies may help solve the ongoing issue with drug shortages. Shawn Hodges, CEO of Revelation Pharma, spoke with Pharmaceutical Executive ...